Search for Clinical Trial Results
Dwarfism - 50 Studies Found
Status | Study |
Completed |
Study Name: Somatropin + Leuprorelin vs Somatropin Alone in Pubertal Children With Idiopathic Short Stature Condition: Idiopathic Short Stature (ISS) Date: 2006-07-18 Interventions:
|
Completed |
Study Name: Predictive Markers in Chinese Growth Hormone Deficiency (GHD) Children Treated With Saizen® Condition: Dwarfism, Pituitary Date: 2010-08-22 Interventions: Drug: Recombinant human growth hormone (r-hGH) Recombinant human growth hormone (r-hGH) administered at |
Active, not recruiting |
Study Name: IGF-1 Treatment for Individuals With Short Stature Due to PAPP-A2 Deficiency Condition: Short Stature Date: 2015-11-10 Interventions: Drug: Increlex Treat PAPP-A2 deficient patients with Increlex |
Completed |
Study Name: Effects of Growth Hormone (GH) Treatment on Eating Regulation Condition: Short Stature Date: 2007-11-21 Interventions:
|
Recruiting |
Study Name: Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children Condition: Dwarfism, Pituitary Date: 2014-11-27 Interventions: Biological: PEG-somatropin |
Completed |
Study Name: National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Patients Condition: Dwarfism, Pituitary Date: 2004-11-24 |
Completed |
Study Name: Efficacy and Safety of Recombinant Human Growth Hormone on Height Velocity in Subjects With Idiopathic Short Stature Condition:
Date: 2013-01-24 Interventions: Drug: somatropin A weekly dosage of 0.469 mg of somatropin per kg of body weight per week will be inject |
Completed |
Study Name: Study of Skeletal Disorders and Short Stature Condition:
|
Completed |
Study Name: Pharmacodynamics of CNP During Growth Hormone Treatment Condition:
|